Thomson Pharma has enjoyed positive coverage in the press, and from customers through a number of testimonials. You can read some of these quotes here, as well as our latest press articles and press releases.

If you'd like to add your own testimonial, or be considered for a case study, please contact us at the appropriate email address given on the right.

View our press fact sheet here.

Customer testimonials

“Thomson Pharma is a best in class database, providing access to the most complete data available in an efficient search engine.”

“Thomson Pharma enables us to keep up-to-date with the latest developments in our customers' pipelines as well as to find potential new customers. We regularly mine the database to find patents, competitive intelligence and new opportunities.”

Brian Robins, Vice President, Davos Chemical Corporation

"I count on Thomson Reuters because it gives me all the information I need in one convenient location — current, accurate, and easy to use.”

Dr James Campbell, VP Operations, ChemGenex Pharmaceuticals Australia

"Thomson Pharma gives us the information we want, filtered using the parameters we defined, for the therapeutic areas we’re interested in, and served in the way each group feels most comfortable with.”

Stuart Newbold, Information Manager, Astex Therapeutics Ltd

“Thomson Pharma gives us that 'at a glance' overview we need to make strategic and positioning decisions, and the ability to drill down to an unprecedented depth of data whenever we need it.”

Dr Yulia Aspinall, Head of Library and Information Services, Cambridge Antibody Technology

“When we search within Thomson Pharma, we're confident we're getting back results that comprise the leading-edge, best available information. The confidence we have using data found in Thomson Pharma is perhaps the product's greatest benefit.”

Tim Grogan, Co-founder, Fusion Life Sciences

Articles

A scientific dialogue at Thomson Scientific
Information World Review, July 2006
Growing fast in a hot sector - scientific research and pharmaceuticals - Tim Hamer explains the challenges facing Thomson Scientific.
 
Thomson Pharma: A modular approach
Interview with Jon Brett Harris, executive vice president of Pharmaceutical and Chemical Markets at Thomson Scientific
 
Flu urges vaccine rush
Pharmaceutical Marketing Europe, Winter 2005
The threat of avian flu is fuelling an already growing interest in the vaccines market. This article includes a look at the obstacles for vaccine manufacturers, and at the response to avian flu by large pharmaceutical companies.
 
The Rise and Rise of Thomson Pharma: The New Model For Pharmaceutical and Biotechnology Information
KnowledgeLink Nov 2005
 
Thomson Scores With Drugs Package
Information World Review Dec 2005
 
Thomson Pharma: The Cure for Pharmaceutical Research
Searcher, Oct. 2005
 

Press releases

Thomson Pharma Chemical Structures Now Indexed in Pubchem Database from US National Institutes of Health
Philadelphia, PA USA, London UK, November 6, 2006
Thomson Scientific today announced the deposit of 2.2 million chemical structures from Thomson Pharma^SM into PubChem, the freely accessible database that provides information on the biological activities of small molecules.
 
Pharmaceutical R&D Factbook Provides Unique Study Of Trends Within The Pharmaceutical Industry
Philadelphia, PA USA, London UK, September 26, 2006
Findings Reveal New Molecular Entities Output Lifts From 20 Year Low
 
Thomson Pharma Enhanced with Global Regulatory Intelligence
Philadelphia, PA USA-London UK, July 5, 2006
New Regulatory Affairs Module helps Thomson Pharma customers build strategies to accelerate entrance of products into the global market
 
Thomson Pharma Now Provides Early Warning of Generic Drug Development Activities
Philadelphia, PA USA-London UK, June 26, 2006
Generic Competition Module Added to Pharmaceutical Information Solution